218 related articles for article (PubMed ID: 27507663)
1. A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer.
Liu Y; Zhang R; Zhao N; Zhang Q; Yan Z; Chang Z; Wei Y; Wu C; Xu J; Xu Y
Mol Biosyst; 2016 Oct; 12(10):3176-85. PubMed ID: 27507663
[TBL] [Abstract][Full Text] [Related]
2. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
3. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.
Liu Y; Zhang R; Qiu F; Li K; Zhou Y; Shang D; Xu Y
Mol Biosyst; 2015 Feb; 11(2):384-93. PubMed ID: 25385343
[TBL] [Abstract][Full Text] [Related]
4. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
6. Inferring and analyzing module-specific lncRNA-mRNA causal regulatory networks in human cancer.
Zhang J; Le TD; Liu L; Li J
Brief Bioinform; 2019 Jul; 20(4):1403-1419. PubMed ID: 29401217
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Jiang T; Guo J; Hu Z; Zhao M; Gu Z; Miao S
Med Sci Monit; 2018 Jun; 24():4213-4239. PubMed ID: 29923546
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
9. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.
Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X
Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
13. LncReg: a reference resource for lncRNA-associated regulatory networks.
Zhou Z; Shen Y; Khan MR; Li A
Database (Oxford); 2015; 2015():. PubMed ID: 26363021
[TBL] [Abstract][Full Text] [Related]
14. Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features.
Zhao T; Xu J; Liu L; Bai J; Xu C; Xiao Y; Li X; Zhang L
Mol Biosyst; 2015 Jan; 11(1):126-36. PubMed ID: 25354589
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.
Du Z; Fei T; Verhaak RG; Su Z; Zhang Y; Brown M; Chen Y; Liu XS
Nat Struct Mol Biol; 2013 Jul; 20(7):908-13. PubMed ID: 23728290
[TBL] [Abstract][Full Text] [Related]
18. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
Wu X; Ruan L; Yang Y; Mei Q
Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
[TBL] [Abstract][Full Text] [Related]
19. lncRNAMap: a map of putative regulatory functions in the long non-coding transcriptome.
Chan WL; Huang HD; Chang JG
Comput Biol Chem; 2014 Jun; 50():41-9. PubMed ID: 24525374
[TBL] [Abstract][Full Text] [Related]
20. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
